In relation to ischemic heart disease, CCL18 was found to be significantly elevated in patients with refractory ischemic symptoms versus stabilized patients [9], and high CCL18 levels were associated with fatal events in 609 patients with acute coronary syndrome (ACS) during a follow-up period of 200 days [10]. This evidence concerns the gene CCL18 and acute coronary syndrome.